1364. Efficacy of Omadacycline Against Molecularly Characterized Gram-Positive and Gram-Negative Pathogens Causing Infections in the Phase 3 CABP and ABSSSI Clinical Trials

por Mendes, Rodrigo E, Castanheira, Mariana, Armstrong, Eliana S, Steenbergen, Judith N, Flamm, Robert K
Publicado 2018

1377. Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms

por Mendes, Rodrigo E, Castanheira, Mariana, Armstrong, Eliana S, Steenbergen, Judith N, Flamm, Robert K
Publicado 2018

Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections

por Armstrong, Eliana S., Mikulca, Janelle A., Cloutier, Daniel J., Bliss, Caleb A., Steenbergen, Judith N.
Publicado 2016

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs

por Crompton, Jason A., North, Donald S., Yoon, MinJung, Steenbergen, Judith N., Lamp, Kenneth C., Forrest, Graeme N.
Publicado 2010

The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome

por Heidrich, Corina G., Mitova, Sanya, Schedlbauer, Andreas, Connell, Sean R., Fucini, Paola, Steenbergen, Judith N., Berens, Christian
Publicado 2016

1347. Omadacycline for Acute Bacterial Skin and Skin Structure Infections: Integrated Analysis of Randomized Clinical Trials

por Abrahamian, Fredrick M, Sakoulas, George, Tzanis, Evan, Manley, Amy, Steenbergen, Judith N, Das, Anita, Eckburg, Paul, McGovern, Paul
Publicado 2018

1561. Omadacycline Pharmacokinetics: Influence of Mortality Risk Score Among Patients with Community-Acquired Bacterial Pneumonia

por Lakota, Elizabeth A, Friedrich, Lawrence, Steenbergen, Judith N, McGovern, Paul C, Tzanis, Evan, Bhavnani, Sujata M, Rubino, Christopher M
Publicado 2019

734. Modeling the Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Omadacycline with and without a Loading Dose

por Friedrich, Lawrence, Curran, Marla, Chitra, Surya, Manley, Amy, Bai, Stephen, Noble, Bob, Steenbergen, Judith N, Garrity-Ryan, Lynne, Tzanis, Evan
Publicado 2019

Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model

por VanScoy, Brian D., Lakota, Elizabeth A., Conde, Haley, McCauley, Jennifer, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Bhavnani, Sujata M.
Publicado 2020

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

por Lakota, Elizabeth A., Van Wart, Scott A., Trang, Michael, Tzanis, Evan, Bhavnani, Sujata M., Safir, M. Courtney, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Rubino, Christopher M.
Publicado 2020

733. Pharmacokinetic–Pharmacodynamic (PK–PD) Analyses for Alanine Aminotransferase (ALT) Using Phase 3 Data From Omadacycline (OMC)-Treated Patients

por Bhavnani, Sujata M, Trang, Michael, George, Darryl R, Liolios, Kathryn, McGovern, Paul C, Friedrich, Lawrence, Steenbergen, Judith N, Rubino, Christopher M, Tzanis, Evan, Ambrose, Paul G, Hammel, Jeffrey P
Publicado 2019

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising...

por Bhavnani, Sujata M., Hammel, Jeffrey P., Lakota, Elizabeth A., Trang, Michael, Bader, Justin C., Bulik, Catharine C., VanScoy, Brian D., Rubino, Christopher M., Huband, Michael D., Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G.
Publicado 2023